Early breast cancer – close collaboration between GP and radiologist.

13th August 2023, NIA Diagnostic Imaging

A 49-year-old lady presented with pain in her right breast. There is a strong family history of breast cancer. Breast examination was difficult because of “lumpiness” of the breasts. She was referred for a breast ultrasound at NIA. Ultrasound showed two lesions in the right breast – one at 3 o’clock, 2cm from the nipple and another at 7 o’clock, 2cm from the nipple.…

Obstetric Imaging – what scans/tests can you order?

29th June 2023, Spectrum Medical Imaging

At Spectrum Medical Imaging, we are pleased to offer your patients a wide range of obstetric imaging options throughout all stages of their pregnancy. We are committed to providing you with high quality services at affordable prices. All of our sonographers who perform Nuchal Translucency scans are certified by the Fetal Medicine Foundation and all of our reporting Radiologists have a special interest in obstetric ultrasound.…

Pelvic organ prolapse – diagnosis with translabial ultrasound

11th June 2023, NIA Diagnostic Imaging

translabial US

The incidence of pelvic organ prolapse is highly associated with increased age and vaginal childbirth (Weintraub et al., 2020). Majority of patients who present with POP may not report any symptoms. Patients who do present with symptoms, however, often describe a sense of feeling of a bulge protruding through the vaginal opening. In younger women, vaginal laxity is more commonly noticed and related to sexual dysfunction (Peter Dietz, 2015).…

TOBOGM has finally published – what has it taught us?

14th May 2023, Dr Chee L Khoo

TOBOGM is the very first study to see if immediate treatment of early gestational diabetes mellitus (GDM) increases or reduces pregnancy complications among women with GDM diagnosed with OGTT before 20 weeks’ gestation. TOBOGM study results will significantly contribute to the management decisions of pregnant women with early GDM. Campbelltown Hospital was the lead recruiting centre with Professor David Simmons being the chief investigator of this international study.…

Anthracycline-induced cardiotoxicity – can we prevent it?

1st April 2023, Dr Chee L Khoo

Cardiotoxicity

Two months ago, we explored heart failure in cancer survivors exposed to anthracyclines in a dose dependent manner. Anthracyclines are a common agents used in chemotherapy against breast cancer and lymphomas. Heart failure may appear as early as within 12 months of receiving anthracyclines and the incidence continues to grow over time. There have been a lot of work done on the possible molecular pathways in the development of the cardiotoxicity, the prevention strategies explored and the development of “safer” anthracycline derivatives.…

Uterine fibroids – another treatment option

Spectrum Medical Imaging, 28th February 2023

Uterine fibroids

Uterine fibroids are benign (non-cancerous) tumours of the
uterus. They are clinically apparent in up to 25% of women
and, with newer imaging techniques, the true clinical
prevalence may be higher (up to 77% ). Although most do
not cause symptoms, uterine fibroids can cause severe
problems for some women who have the condition.…

Different breasts, different densities hence, different screening techniques

29th January 2023, Spectrum Medical Imaging

Breasts not only come in different sizes and shapes but have different composition and densities. The breast density also changes with age, body composition and genetic factors. 50% of women in the US have dense breasts and dense breast tissue can camouflage early breast cancer. Yet, we only have standardised mammography and screening schedules. The Volpara is an AI software platform that provides an individualised risk assessment and screening recommendations based on the composition of the breast of the woman.…

Bloody nipple discharge – a cause for concern?

14th January 2023, NIA Diagnostic Imaging

Despite the availability of modalities such as mammography, MRI and galactography, ultrasound still has a role in breast imaging. Ultrasound provides high resolution portrayal of normal and abnormal breast parenchyma as well as clear depiction of lactiferous ducts and the terminal duct-lobular unit where masses can form (4). This is particularly useful when investigating women presenting with a bloody nipple discharge.…

Pelvic pain in first trimester – differential diagnosis

13th Decemer 2022, NIA Diagnostic Imaging

Pelvic pain

Pelvic pain is a common presentation in general practice. It becomes a little bit more complicated if that occurs during the first trimester of pregnancy. To the usual gynaecological and non-gynaecological causes, we have to add the other obstetric causes of pelvic pain. The obstetric causes during the 1st trimester can be a serious concern and should be treated as an urgent matter.…

Diabetes Foetal Programming – before the beginning…

13th November 2022, Dr Chee L Khoo

Gestational diabetes mellitus (GDM) is one many factors that changes future generations. Maternal overnutrition, and excessive gestational weight gain with or without GDM lead to foetal overgrowth, and “programs” the offspring with an increased risk of obesity and type 2 diabetes mellitus (T2D) in childhood and adulthood. The aetiology of obesity and T2D is multifactorial and involves complex interactions between genetic, environmental and behavioural factors.…

EARLY BREAST CANCER DETECTION – NO COMPROMISE WITH 3D MAMMOGRAPHY

13rd September 2022, NIA Diagnostic Imaging

Mammography remains the gold standard imaging technique in early-stage breast cancer diagnosis. It forms part of the triple test approach to the investigation of new breast symptoms. (Cancer Australia 2021). In the past, there used to be limitations with conventional mammography’s sensitivity and specificity in detecting abnormalities in young female breasts due to the patients’ mostly dense breast tissues.…